CHELMSFORD, Mass.--(BUSINESS WIRE)--The American Heart Association (AHA), American College of Cardiology (ACC), and Heart Rhythm Society (HRS) have issued guidelines for the wearable cardioverter ...
GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...
Advanced second- or third-degree AV block, with symptomatic bradycardia, ventricular dysfunction or low cardiac output. Sinus node dysfunction with symptoms during age-inappropriate bradycardia.
(HealthDay)—For patients with heart failure with indications for cardiac resynchronization therapy (CRT), those with ischemic cardiomyopathy (ICM), but not those with nonischemic dilated ...
KANSAS CITY, Mo. — An estimated 750,000 hospitalized patients experience cardiac arrest and undergo CPR annually, and less than 30 percent of those leave the hospital alive. In a paper published in ...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...
Disrupting the status quo is no easy feat, especially when you're already a leader in cardiac rhythm management. Yet, Medtronic seems to have achieved just that with its OmniaSecure defibrillation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results